Document is current
Any future updates will be listed below
-
Authors
Ding, Chengyi
O’Neill, Dara
Bell, Steven
Stamatakis, Emmanuel
Britton, Annie
-
Funding
Funding for this research was provided by:
Economic and Social Research Council (ES/K000357/1)
National Institute for Health Research (NIHR BTRU-2014-10024)
UK Medical Research Council (MR/L003120/1)
British Heart Foundation (SP/09/002; RG/13/13/30194; RG/18/13/33946)
- License Information
-
More Information
Article History
Received: 2 March 2021
Accepted: 17 June 2021
First Online: 27 July 2021
Declarations
:
: This study is a secondary analysis of previously collected data and so additional ethical approval was not required. Ethics approvals for HSE 1994-97 were granted by Local Research Ethics Committees in England, HSE 1998-99 by London North Thames Multicentre Research Ethics Committee (MREC/97/2/9, MREC/98/2/89), HSE 2000-07 by London Multicentre Research Ethics Committee (MREC/99/2/91, MREC/00/2/81, MREC/01/2/82, MREC/02/2/72, MREC/03/2/97, 04/MRE02/50, 05/MREC02/47, 06/MRE02/62), and HSE 2008 by Oxford A-Research Ethics Committee (07/H0604/102). SHeSs 1995 and 1998 were approved by all fifteen of the Research Ethics Committees for all Area Health Boards in Scotland, and SHeSs 2003 by Multicentre Research Ethics Committee for Scotland. All participants gave verbal consent to be interviewed for the survey. UK Biobank received approval from the North West Centre for Research Ethics Committee (11/NW/0382) and all participants gave written informed consent.
: Not applicable.
: Dr Steven Bell is Editorial Board Member for BMC Medicine. The authors declare that they have no competing interests.
